Pillar 05

Getting ready for the next generation of malaria solutions

Led by RBM’s Vector Control Working Group (VCWG) and Case Management Working Group (CMWG), this pillar prepares policies, systems, and communities for rapid and equitable introduction of new tools — from vaccines to next-generation nets and novel therapeutics.

Pillar 5 Updates

Strategic Dialogue on New Malaria Tools​​​​‌‍​‍​‍‌‍‌​‍‌‍‍‌‌‍‌‌‍‍‌‌‍‍​‍​‍​‍‍​‍​‍‌‍‌​‌‍​‌‌‌​‌‍‌‍​‌‍‌‌​​‍‍‌‍​‌‍‌‍‌​‍​‍​‍​​‍​‍‌‍‍​‌​‍‌‍‌‌‌‍‌‍​‍​‍​‍‍​‍​‍‌‍‍​‌‌​‌‌​‌​​‌​​‍‍​‍​‍‌‍​‌​‍‌‌‍​‍‌‍‍‌‌‍‌‌​​‌‌‌‌​‌‍‍​​‍‍‌‍‌‌‌‍‍‌‍‌​‌‍‌‌‍​‌‌‍​‌‍​‌‌​‍‌‍‍‌‌‍​‌​‍‍‌‍‌​‍‌‍‌​‍‌‍‌‌‌‍‌​‌‍‍‌‌‌​‌‍‌​‍​‍‌‍‍‌‌‌​‌‍‌‌‌‍‌‌‌‌‌​‌‍‌‌​​‌‍‌‌‌​​‍‌‌​‌‌‌​‌​‌‌‍‌​‌​‌‍‍‌‍‍‍‌‍‌​‌‌​‍‌‍‍‌‌‌‌‌​‍​‍‌‌‍‍‌​‍​‍‌‌‌​‌‍​‍‌​‍​‍​‌‌‌‍‌​​‌​‍‌‍‍‌‌‌​‌‍‌‌‌‍‌‌​​‍‌‌‍​‌​‌‌‌‍‌‌‌‌‌‌​‌‌​‌‌​‍‌‌‍‍​‌‌​‌‌‌‌‌​‌​‌‌​‍​​​‌​‌​​‌​‌‌‌‍‌‍‌‌​‌​‌​‌​‍‌​​‌​‍‌‍‌‌‌‍‌​‌‍‍‌‌‌​​‍​‌‍‌‍‌‍‍‌‌‍‌‌‌‍​‌‍‌​‌‌​​‌‍​‌‌‌​‌‍‍​​‌‌‍​‌‍‌‍‍‌‌​‌‍‌‌‌‍‍‌‌​​‍‍‌‍‌‌‌‍‍​‍‍​​​​‍‍‌‌​‌‍‍‌‌‌​‌‍​‌‍‌‌​‍​‍‌‌

The RBM Partnership to End Malaria, together with the Government of Uganda, convened a three-day Strategic Dialogue in Kampala from 23 to 25 March 2026. The purpose was to define a coordinated action framework to move new malaria tools faster from approval to country use. ​​​​

On the sidelines of the Dialogue, the RBM Partnership CEO visited Quality Chemicals Industries Limited (QCIL), the National Medical Stores, and Uganda Virus Research Institute / Target Malaria to learn more about the country's manufacturing capacity, supply chain systems, and innovations.‌‍​‍​‍‌‍‌​‍‌‍‍‌‌‍‌‌‍‍‌‌‍‍​‍​‍​‍‍​‍​‍‌‍‌​‌‍​‌‌‌​‌‍‌‍​‌‍‌‌​​‍‍‌‍​‌‍‌‍‌​‍​‍​‍​​‍​‍‌‍‍​‌​‍‌‍‌‌‌‍‌‍​‍​‍​‍‍​‍​‍‌‍‍​‌‌​‌‌​‌​​‌​​‍‍​‍​‍‌‍​‌​‍‌‌‍​‍‌‍‍‌‌‍‌‌​​‌‌‌‌​‌‍‍​​‍‍‌‍‌‌‌‍‍‌‍‌​‌‍‌‌‍​‌‌‍​‌‍​‌‌​‍‌‍‍‌‌‍​‌​‍‍‌‍‌​‍‌‍‌​‍‌‍‌‌‌‍‌​‌‍‍‌‌‌​‌‍‌​‍​‍‌‍‍‌‌‌​‌‍‌‌‌‍‌‌‌‌‌​‌‍‌‌​​‌‍‌‌‌​​‍‌‌​‌‌‌​‌​‌‌‍‌​‌​‌‍‍‌‍‍‍‌‍‌​‌‌​‍‌‍‍‌‌‌‌‌​‍​‍‌‌‍‍‌​‍​‍‌‌‌​‌‍​‍‌​‍​‍​‌‌‌‍‌​​‌​‍‌‍‍‌‌‌​‌‍‌‌‌‍‌‌​​‍‌‌‍​‌​‌‌‌‍‌‌‌‌‌‌​‌‌​‌‌​‍‌‌‍‍​‌‌​‌‌‌‌‌​‌​‌‌​‍​​​‌​‌​​‌​‌‌‌‍‌‍‌‌​‌​‌​‌​‍‌​​‌​‍‌‍‌‌‌‍‌​‌‍‍‌‌‌​​‍​‌‍‌‍‌‍‍‌‌‍‌‌‌‍​‌‍‌​‌‌​​‌‍​‌‌‌​‌‍‍​​‌‌‍​‌‍‌‍‍‌‌​‌‍‌‌‌‍‍‌‌​​‍‍‌‍‌‌‌‍‍​‍‍​​​​‍‍‌‍​‌‍‌‍‍‌‌​‌‍‌‌‌‍‍‌‌​​‍​‍‌‌

How we track progress

12KPI 5.1Quarterly

TBC

Source: Unitaid Dashboard

The challenge

The malaria pipeline is delivering breakthrough innovations — vaccines, next-generation insecticide-treated nets, monoclonal antibodies, and gene drive technologies. But innovation alone is not enough.

The gap between WHO approval and nationwide rollout can stretch to years. Slow policy adoption, unprepared delivery infrastructure, unfunded scale-up plans, and communities that have not been engaged all contribute to delays that cost lives. Readiness must be built before tools arrive, not after.

The Big Push: From Today to Tomorrow

Today
2030
TodayNew tools take too long to be approved and introduced
2030Investment supports the development of transformational malaria tools
TodayProcesses are complex and not well-aligned
2030Regulatory and policy processes are faster and better aligned
TodayCountries are not always ready to adopt new tools
2030New tools are affordable, accessible, and scaled up quickly by countries

Connected Progress

New tool readiness depends on every other pillar

Rapid, equitable introduction of new tools requires coordination for aligned rollout across partners, national leadership for swift policy adoption, data infrastructure for targeting and post-introduction monitoring, robust delivery systems for equitable access, and sustained funding for procurement and scale-up. Readiness is not one capability — it is all of them working together.